Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biondvax Pharma ADR (BVXV)

Biondvax Pharma ADR (BVXV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biondvax Pharma ADR JERUSALEM BIOPARK 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 ISR

www.biondvax.com P: 972-8930-2529

Description:

BiondVax Pharmaceuticals Ltd. is a biopharmaceutical company. The company's product includes Multimeric-001 universal flu vaccine which provides multi-season and multi-strain protection against human influenza virus strains. BiondVax Pharmaceuticals Ltd. is based in Ness Ziona, Israel.

Key Statistics

Overview:

Market Capitalization, $K 2,540
Enterprise Value, $K 8,400
Shares Outstanding, K 1,868
Annual Sales, $ 0 K
Annual Net Income, $ -5,800 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,760 K
EBIT, $ -7,720 K
EBITDA, $ -7,160 K
60-Month Beta 2.37
% of Insider Shareholders 6.03%
% of Institutional Shareholders 11.83%
Float, K 1,755
% Float 93.97%
Short Volume Ratio 0.76

Growth:

1-Year Return -86.74%
3-Year Return -99.65%
5-Year Return -97.61%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 79.80%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.11 on 08/11/23
Next Earnings Date 08/24/23
Earnings Per Share ttm -2.55
EPS Growth vs. Prev Qtr 7.50%
EPS Growth vs. Prev Year 47.14%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 11/25/22

BVXV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -29.52%
Profit Margin % 0.00%
Debt/Equity -3.28
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -3.80
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar